Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer

The discovery of an echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion gene led to improved clinical outcomes in patients with lung cancer after the development of the first ALK-targeting agent, crizotinib. Some second-generation ALK tyrosine kinase inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Isozaki, Hideko, Takigawa, Nagio, Kiura, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491683/
https://www.ncbi.nlm.nih.gov/pubmed/25941796
http://dx.doi.org/10.3390/cancers7020763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491683/
https://www.ncbi.nlm.nih.gov/pubmed/25941796
http://dx.doi.org/10.3390/cancers7020763

Ejemplares similares